Exosomes in Aesthetic Medicine — Why We Don’t Use Them
Exosomes have become one of the most talked-about innovations in aesthetic medicine. Marketed as regenerative treatments capable of rejuvenating the skin, improving texture, and stimulating collagen, they are being promoted as a scientific breakthrough in beauty.
However, we believe in science first, trends second.
Before offering any treatment, we require solid clinical evidence, medical approval, and a proven safety record. That’s why we don’t use exosomes — at least not yet.
What Exactly Are Exosomes?
Exosomes are microscopic vesicles naturally released by cells. They act as messengers, carrying proteins, lipids, and genetic material to other cells.
In laboratory studies, they appear to support processes like tissue repair and inflammation control — which sounds promising.
But what happens in the lab doesn’t always translate safely to human skin.
What the Evidence Really Shows
When it comes to human clinical research, the data available today is still very limited and scientifically weak.
The few existing studies include small patient numbers, usually fewer than 20 participants.
They are not randomised or controlled, which means results are easily influenced by placebo effects or bias.
There is no long-term follow-up — we don’t know the outcomes after several months or years.
Many studies are industry-sponsored, not independently reviewed or published in major medical journals.
In short, there are no large, peer-reviewed, randomised clinical trials that confirm either the efficacy or safety of exosomes in aesthetic use.
What has been published so far are isolated case reports and pilot studies with no consistent or statistically valid results.
The Risk Behind the Hype
Despite the lack of rigorous data, exosome-based treatments are already being promoted by some aesthetic clinics and suppliers.
This raises serious safety and ethical concerns:
No regulatory approval: No exosome product used for cosmetic purposes has been approved by the FDA, EMA, or HPRA.
Unclear manufacturing standards: Many products come from unverified sources such as umbilical cord or placental tissue, with no standardisation or quality control.
Unknown long-term effects: Because exosomes carry genetic material, their immune and inflammatory impactis not yet understood. Adverse reactions — such as inflammation, granulomas, or allergic responses — have been reported.
Ethical responsibility: Patients trust medical professionals to recommend safe, evidence-based treatments. Offering experimental products without scientific backing compromises that trust.
The cosmetic market moves fast, but medicine must move responsibly.
Our Position
At our clinic, patient safety always comes first.
We continuously monitor new technologies and scientific publications, but we only introduce treatments that have been proven effective, safe, and medically justified.
Until exosome therapy is supported by strong, peer-reviewed research and regulatory approval, we won’t use it.
Our role as medical professionals is to protect our patients — not to experiment on them.
We believe real results come from science, not speculation.
In Summary
We are not against innovation — we are against unsafe innovation.
Exosomes may have potential, but at this stage, they remain unproven.
Our commitment is to provide treatments that meet the highest medical standards, supported by solid evidence and guided by ethical responsibility.
Because your safety will always be our top priority.
